SBWire

GlobalData's new report, "Spain Nuclear Imaging Equipment Market Outlook to 2020", provides key market data on the Spain Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).

GlobalData's new report, "Mexico X-ray Systems Market Outlook to 2020", provides key market data on the Mexico X-ray Systems market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Analog X-ray Systems, Digital X-ray Systems (Computed Radiography (CR) Systems and Digital Radiography (DR) Systems) and Retrofit X-ray Systems.

Serbia spends over 10% of GDP on healthcare, the highest proportion in Central & Eastern Europe (CEE). However, Serbia is one of the poorest countries in Central & Eastern Europe (CEE), in per capita terms. In 2013, GDP per capita stands at US$6,159, around half that found in Russia. The economy is expected to register real growth of 1.3% in 2013, but is forecast to increase by an average 4.0% per annum between 2014 and 2018. According to the 2013 budget, the government is aiming to reduce the budget deficit from 6.5% of GDP in 2012 to 3.6% in 2013 in order to increase its prospects of rejoining the IMF Stand-By Arrangement. It aims to achieve this through increases in VAT, corporate and income taxes; real reductions in pensions and public sector wages; and cuts in subsidies.

GlobalData's new report, "Spain C-Arms Market Outlook to 2020", provides key market data on the Spain C-Arms market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market category.

The Belarusian medical device market is small and under-developed. Key metrics, such as health expenditure per capita and medical device spending, are the lowest in Europe. An ailing economy and a political regime resistant to market modernisation, and therefore unattractive to investors, are both dominating factors which limit the development of the healthcare sector and dampen demand.

Canada is geographically one of the world's largest countries, but has a population of just 35.0mn. The population is unevenly spread, with 90% of Canadians living near the US border. The economy is highly developed, GDP per capita is on a par with the US.

The Europe Medical Devices Reports provide the latest available data, expert analysis and our independent 5-year forecasts for key European markets. Each country report covers political risk, the business environment, and macro-economic and industry prospects set against assumptions for the global economy.

The medical equipment market is small, constrained by the country's small size. It is, however, one of the richest markets in the European region when viewed on a per capita basis. In 2013, the medical device market is estimated at US$314.8mn, equal to US$154.0 per capita, and equivalent to 7.3% of total health expenditure, 0.7% of GDP and 0.1% of the world market. The market is expected to grow by a 2013-2018 CAGR of 2.8% over the next five years, reaching US$360.7mn in 2018.

The Northern European countries are projected to represent a combined medical device market value of US$8.7 billion by 2017 The seven Northern European medical device markets are diverse, from the stable well-developed markets of Scandinavia to the less well-funded healthcare systems of the Baltic States. The Eurozone crisis is affecting these markets but opportunities still exist. Healthcare provision remains a high priority for governments in the region and countries such as Sweden are keen to be at the forefront of technological development.

Although the Greek economy is still stuck in the doldrums, a spate of positive economic developments in recent months has fuelled a stellar market rally in bonds and equities, and has provided some much needed respite for the hardened coalition. On the macro front, a continued slowdown in the rate of economic contraction, coupled with a pickup in consumer sentiment, suggests that the acute phase of the crisis is gradually giving way to a period of stabilisation. A return to positive growth and a sustainable recovery is still some way off, but following five years of depression, the worst has now past. In 2013, GDP is expected to decrease by 4.2% in real terms to US$247.2bn, equal to US$21,602 per capita.

GlobalData's new report, "Asia-Pacific Knee Reconstruction Market Outlook to 2020", provides key market data on the Asia-Pacific Knee Reconstruction market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Primary Knee Replacement, Revision Knee Replacement and Partial Knee Replacement.

GlobalData's new report, "BRIC Orthopedic Tools Market Outlook to 2020", provides key market data on the BRIC Orthopedic Tools market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Orthopedic Power Tools and Orthopedic Reamers.

South Africa is among the top 30 most populous countries in the world with an estimated population of 51.0mn in 2013. The population is relatively young and the dire AIDS situation is having a negative impact on population growth, despite the country having one of the highest birth rates in the world at around 22 live births per thousand population.

Public hospitals struggle to fund upgrades to facilities; a change of regulations in 2012 means that public hospitals can now access funding directly from credit institutions, including the Vietnam Development Bank. As of January 2013, 18 hospitals had applied for funding with six hospitals signing contracts for loans totalling VND900bn (US$43.2mn).

Highlights from the Region

At an estimated US$127.1bn in 2013, the US medical device market is the world's largest. Per capita expenditure, at US$399, is the highest in the world.

Despite on-going economic pressures, the medical device and equipment industry is one of the most successful in terms of its operation. Many leading companies continue to dominate key markets through product innovation, acquisition and mergers, and the sector supports thousands of SME's developing and sharing novel medical technologies.

Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions.

Bulgaria is located in south-eastern Europe, bordering Romania, Serbia, Macedonia, Greece and Turkey and is one of the newest members of the EU, joining in January 2007, alongside Romania. The population of Bulgaria is estimated at 7.3 million in 2013, 18.4% of whom are aged 65 or over. The Prime Minister of Bulgaria is Boyko Borissov, leader of the GERB and former major of Sofia. The current president is Rosen Plevneliev, who took office in January 2012.

GlobalData's new report, "Spain X-ray Systems Market Outlook to 2020", provides key market data on the Spain X-ray Systems market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Analog X-ray Systems, Digital X-ray Systems (Computed Radiography (CR) Systems and Digital Radiography (DR) Systems) and Retrofit X-ray Systems.

Sweden is faced with one of the largest elderly populations proportionally in the world. Healthcare provision remains a high government priority. Consequently, the government is heavily promoting preventative care in an effort to reign in ever rising healthcare expenditure.

Although a relatively small market, Austria has a high level of per capita spending on medical devices. The market for medical equipment and supplies is valued at US$2,527mn in 2013, equal to US$299 per capita.

Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient's body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions.

GlobalData's new report, "France Arthroscopy Devices Market Outlook to 2020", provides key market data on the France Arthroscopy market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Arthroscopy Implants, Arthroscopy Radio Frequency Wands, Arthroscopy Fluid Management Systems, Arthroscopes, Arthroscopic Shavers, Arthroscopy Radio Frequency Systems and Arthroscopy Visualization Systems.

The economy aside, what factors are affecting medical device growth? Fundamentally, the eight countries covered in this collection share a similar characteristic. These medical device markets have, on average, been growing at more attractive rates compared to the more developed, mature medical device markets in Western Europe, for example.